Premium
Arterial thromboembolic complications in COVID‐19 in low‐risk patients despite prophylaxis
Author(s) -
Griffin Daniel O.,
Jensen Alexandra,
Khan Mushmoom,
Chin Jessica,
Chin Kelly,
Parnell Ryan,
Awwad Christopher,
Patel Darshan
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16792
Subject(s) - medicine , tocilizumab , methylprednisolone , intensive care unit , incidence (geometry) , complication , thrombosis , pulmonary embolism , coagulopathy , disseminated intravascular coagulation , surgery , pediatrics , disease , physics , optics
We present a case series of three patients with COVID-19 who developed arterial vascular complications, one who developed an acute CVA, one who developed popliteal artery occlusion and one who developed both during their hospital course. We present a case series of three patients admitted to Northwell Plainview Hospital in Plainview, New York with COVID-19 as confirmed by PCR. The clinical disease course of COVID-19 has been well documented in China and Europe and most recently, the United States. Publications highlighting the non-respiratory complications of COVID-19 have been limited.[1, 2] Acute cardiac injury and arrhythmia in the ICU have been described as major complications of COVID-19.[3] A few publications have highlighted the incidence of venous thromboembolic complications in COVID-19.[4, 5].